607.00
+9(+1.51%)
Currency In JPY
Address
Shibuya Mitake Building
Tokyo, 150-0002
Japan
Phone
81 3 6455 5308
Website
Sector
Healthcare
Industry
Biotechnology
Employees
151
First IPO Date
October 29, 2019
| Name | Title | Pay | Year Born |
| Mr. Takashi Sawada | President, Chief Executive Officer & Representative Director | 0 | 1957 |
| Mr. Masato Tsumamoto | CXO, Chief Transformation Officer & Director | 0 | 1982 |
| Kaoru Hosoda | Chief Operating Officer, GM of Contract Processing Business Division & Executive Officer | 0 | N/A |
| Mr. Masayuki Yamakawa M.D. | Executive Chairman & MD | 0 | 1964 |
| Mr. Yuta Hayashi | Chief Strategy Officer, GM of Corporate Strategy Division & Executive Officer | 0 | N/A |
| Mr. Tomohiro Iga | GM of Corporate Division & Executive Officer | 0 | 1970 |
CellSource Co., Ltd. engages in the regenerative medicine-related and consumer businesses. It also offers Signalift, an anti-aging product. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.